Gilead Sciences

Gilead Sciences

Gilead Sciences

Official Twitter feed for news and updates from Gilead Sciences.Gilead's Twitter guidelines can be found here on our site
Type
B2b
Founded
1987
Follow us
Alexa global traffic share
Twitter followers
FinSMEs , thetechstartups

Gilead Sciences to Buy Immunomedics

Pulse 2.0

Gilead Sciences (GILD) Reportedly Planning To Buy Immunomedics (IMMU) For Over $20 Billion

Xconomy

Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug

Xconomy

Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire

SiliconRepublic

Gilead Sciences to create 140 new jobs in Ireland amid €7m investment

Pulse 2.0

Gilead Sciences (GILD) Stock: Should I Buy It Now?

CCN Markets

Gilead Sciences Stock Is Rallying - And the Reason Why May Sicken You

FinSMEs

Gilead Sciences To Acquire 49.9 % Equity In Pionyr Immunotherapeutics, For $275M

Pulse 2.0

Gilead Sciences (GILD) Signs $2 Billion Deal With Arcus Biosciences (RCUS)

Pulse 2.0

Report: Gilead Sciences (GILD) Could See Over $2 Billion In Sales From Remdesivir

CCN Markets

Why It’s Too Early to Celebrate Gilead Sciences' Coronavirus Therapy

SiliconBeat

Coronavirus: Stocks rally on Gilead Sciences’ upbeat treatment report

Forbes

Stocks This Week: Buy Juniper Networks And Gilead Sciences And Short Noble

MedCity News

Gilead Sciences, Tango Therapeutics join forces on immuno-oncology

San Francisco Chronicle

Gilead Sciences to spend billions on gene-editing cures for cancer

Health Science
The Motley Fool

3 Biotech Stocks to Buy Now for the Long Haul

The Motley Fool

Can Gilead Sciences Rebound in the Second Half of 2016?

The Motley Fool

Can These Upstarts Knock Gilead Sciences Off Its Perch?

The Motley Fool

Gilead Sciences: Where's the Value?

The Motley Fool

The 3 Best Dividend Stocks for Beginning Investors